Maximum quantity allowed is 999
Please select the quantity
CAS RN: 53-85-0 | Product Number: D4292
5,6-Dichlorobenzimidazole 1-β-D-Ribofuranoside
×
![]()
×
Purity: >98.0%(HPLC)(N)
Synonyms:
- 5,6-Dichlorobenzimidazole Riboside
- 5,6-Dichloro-1-(β-D-ribofuranosyl)benzimidazole
- DRB
Product Documents:
| Size | Unit Price | Same Day | 2-3 Business Days | Other Lead Time |
Shipping Information
|
|---|---|---|---|---|---|
| 100MG |
$115.00
|
19 | 0 | It can be shipped in about 2 weeks after ordering | |
| 1G |
$599.00
|
2 | 14 | It can be shipped in about 2 weeks after ordering |
* Please contact our distributors or
TCI
to order our products. The above prices do not include freight cost, customs, and other charges to the destination.
* The storage conditions are subject to change without notice.
| Product Number | D4292 |
Purity / Analysis Method 
|
>98.0%(HPLC)(N) |
| Molecular Formula / Molecular Weight | C__1__2H__1__2Cl__2N__2O__4 = 319.14 |
| Physical State (20 deg.C) | Solid |
| Storage Temperature
|
Frozen (<0°C) |
| Condition to Avoid | Heat Sensitive |
| Packaging and Container
|
100MG-Glass Bottle with Plastic Insert (View image) |
| CAS RN | 53-85-0 |
| Reaxys Registry Number | 39123 |
| PubChem Substance ID | 253660379 |
| MDL Number | MFCD00036785 |
Specifications
| Appearance | White to Almost white powder to crystal |
| Purity(HPLC) | min. 98.0 area% |
| Purity(with Total Nitrogen) | min. 98.0 % |
| Melting point | 220.0 to 224.0 °C |
| Specific rotation [a]20/D | -66.0 ～ -68.0 deg(C=2, Pyridine) |
Properties (reference)
| Melting Point | 222 °C |
| Specific Rotation | -67° (C=2,Pyridine) |
| Maximum Absorption Wavelength | 296 nm |
GHS
Related Laws:
| RTECS# | DD7310000 |
Transport Information:
| H.S.code* | 2934.99-000 |
Application
5,6-Dichlorobenzimidazole 1-β-D-ribofuranoside (DRB): A Selective Inhibitor of Transcription Elongation by RNA Polymerase II
5,6-Dichlorobenzimidazole 1-β-D-ribofuranoside (DRB) is a selective inhibitor of transcription elongation by RNA polymerase II, and then it inhibits of mRNA synthesis in eukaryotic cells. The inhibition can trigger p53-dependent apotosis of tumor cells. DRB can also inhibit HIV transcription by targeting elongation enhanced by the HIV-encoded transactivator (Tat).
References
- 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription elongation by RNA polymerase II in vitro
- The transcriptional elongation inhibitor 5,6-dichloro-1-β-D-ribofuranosylbenzimidazole inhibits transcription factor IIH-associated protein kinase
- Inhibition of RNA polymerase II as a trigger for the p53 response
- DSIF and NELF interact with RNA polymerase II elongation complex and HIV-1 Tat stimulates P-TEFb-mediated phosphorylation of RNA polymerase II and DSIF during transcription elongation
- Halogen Bonds Form the Basis for Selective P-TEFb Inhibition by DRB
PubMed Literature
Product Articles
[TCIMAIL No.164] DRB : A Selective Inhibitor of Transcription Elongation by RNA Polymerase IIProduct Documents (Note: Some products will not have analytical charts available.)
Safety Data Sheet (SDS)
Please select Language.
The requested SDS is not available.
Please Contact Us for more information.
Specifications
C of A & Other Certificates
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
Sample C of A
This is a sample C of A and may not represent a recently manufactured lot of the product.
A sample C of A for this product is not available at this time.
Analytical Charts
Please enter Lot Number
Incorrect Lot Number. Please input only the 4-5 alphanumeric characters before the hyphen.
The requested analytical chart is not available. Sorry for the inconvenience.